Journal Information
Vol. 54. Issue 6.
Pages 598-600 (1 June 2001)
Share
Share
Download PDF
More article options
Vol. 54. Issue 6.
Pages 598-600 (1 June 2001)
Full text access
Osteodistrofia hereditaria de Albright. Identificación de una mutación original en una familia
Albright hereditary osteodystrophy: Identification of a novel mutation in a family
Visits
19748
M. Bastida Eizaguirrea,
Corresponding author
mbastida@hsan.osakidetza.net

Correspondencia: Servicio de Pediatría. Hospital Santiago Apóstol. Olaguibel, 29. 01004 Vitoria-Gasteiz.
, R. Iturbe Ortiz de Urbinaa, M.J. Arto Urzainquia, R. Ezquerra Larreinab, J. Escalada San Martínb
a Servicios de Pediatría. Hospital Santiago Apóstol. Vitoria.
b Servicios de Endocrinología. Hospital Santiago Apóstol. Vitoria.
This item has received
Article information

Se estudian las mutaciones en el gen GNAS1, en un paciente con alteraciones somáticas propias de osteodistrofia hereditaria de Albright y resistencia en los efectores hísticos a la hormona paratiroidea (seudohipoparatiroidismo Ia), y en su madre solamente con alteraciones somáticas y braquimetacarpia (seudoseudohipoparatiroidismo). Se identifica una mutación designada 794G > A en el exón 10 del gen GNAS1, en el ADN del paciente y de su madre. Esta mutación original en el exón 10 del gen GNAS1, es patogénica y confirma el diagnóstico de osteodistrofia hereditaria de Albright

Palabras clave:
Seudohipoparatiroidismo
Seudoseudohipoparatiroidismo

Studies to detect mutations in the GNAS1 gene were performed in a male patient with features of Albright hereditary osteodystrophy and resistance of target tissues to parathyroid hormone (Pseudohypoparathyroidism Ia). The same investigations were carried out in the patient's mother who showed somatic features of Albright's hereditary osteodystrophy and brachymetacarpia without resistance to parathyroid hormone (Pseudopseudohypoparathyroidism). A point mutation designated c.794G > A (R 265 H) in exon 10 of GNAS1 was identified in DNA from the patient and his mother. This novel mutation in exon 10 of GNAS1 c.794 G > A, is pathogenic and confirms a diagnosis of Albright hereditary osteodystrophy

Key words:
Pseudohypoparathyroidism
Pseudopseudohypoparathyroidism
Full text is only aviable in PDF
Bibliografía
[1.]
Z. Farfel, H.R. Bourne, T. Liri.
The expanding spectrum of G proteins diseases.
N Engl J Med, 340 (1999), pp. 1012-1020
[2.]
R.J. Lefkowitz.
G proteins in medicine.
N Engl J Med, 332 (1995), pp. 186-187
[3.]
M.D. Ringel, W.F. Schwindiger, M.A. Levine.
Clinical implications of genetic defects in G proteins.
Medicine, 75 (1996), pp. 171-184
[4.]
V. Schuster, T. Eschenhagen, K. Kruse, P. Gierschik, H.W. Kreth.
Endocrine and molecular biological studies in a German family Bwith Albright Hereditary osteodystrophy.
Eur J Pediatr, 152 (1993), pp. 182-189
[5.]
D. Yu, S. Yu, V. Schuster, K. Kruse, C.L. Clericuzio, L.S. Weinstein.
Identification of two novel delection mutations within the Gs alpha gene (GNAS1) in Albright hereditary osteodystrophy.
J Clin Endocrinol Metab, 84 (1999), pp. 3254-3259
[6.]
Hayward BE, Bonthron DT. An imprinted antisense transcript at the human GNAS1 locus. Hum Mol Genet 2000; 835-841
[7.]
J.M. Nakamoto, A.T. Sandstrom, A.S. Brickman, R.A. Christeton, C. Van Dop.
Pseudohypoparathyroidism type Ia from maternal but not paternal transmission of Gs alpha gene mutation.
Am J Med Genet, 77 (1998), pp. 261-267
[8.]
A. Simon, H.P. Koppeschaar, J.F. Roijers, J.W. Hoppener, C.J. Lips.
Pseudohypoparathyroidism type Ia. Albrignt hereditary osteodystrophy: a model for resarch on G protein-coupled receptors and genomic imprinting.
Neth J Med, 56 (2000), pp. 1100-1109
[9.]
U. Weiss, R. Ischia, S. Eder, P. Lovisetti-Scamihorn, R. Bauer, R. Fischer- Colbrie.
Neuroendocrine secretory protein 55(NESP55): alternative splicing onto transcripts of the GNAS gene and posttranslational processing of a maternally expresed protein.
Neuroendocrinology, 71 (2000), pp. 177-186
[10.]
D.R. Warner, P.V. Gejman, R.M. Collins, L.S. Weinstein.
A novel mutation adjacent to the switch III domain of Gs (alpha) in a patient with pseudohypoparathyroidism.
Mol Endocrinol, 11 (1997), pp. 1718-1727
[11.]
D.R. Warner, R. Romanowski, S. Yu, L.S. Weinstein.
Mutagenesis of the conserved residue Glu259 of Gs alpha demonstrates the importance of interactions between switches 2 and 3 for activation.
J Biol Chem, 274 (1999), pp. 4977-4984
[12.]
S.F. Ahmed, P.H. Dixon, D.T. Bonthron, H.F. Stirling, D.G. Barr, C.J. Kelnar.
GNAS1 mutational analysis in pseudohypoparathyroidism.
Clin Endocrinol (Oxf), 49 (1998), pp. 525-531
[13.]
H. Shapira, M. Mouallen, M.S. Shapiro, Y. Weisman, Z. Farfel.
Pseudohypoparathyroidism type Ia: two new heterozygotus frameshift mutations in exons 5 and 10 of the Gs alpha gene.
Hum Genet, 97 (1996), pp. 73-75
[14.]
L.S. Weinstein, P.V. Gejman, E. Friedman, T. Kadowaki, R.M. Collins, E.S. Gershon.
Mutation pf the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis.
Proc Natl Acad Sci USA, 87 (1990), pp. 8287-8290
[15.]
Coutant R, Carel JC, Mathivon L, Boisson Lesage C, Renier D, Garabedian M et al. Primary hypothyroidism revealing pseudohypoparathyroidism without hypocalcemia and hyperphosphoremia. Arch Pediatr 1997; 433-437.
[16.]
U. Walden, R. Weissortel, Z. Corria, D. Yu, L. Weinstein, K. Kruse.
Stymulatory guanine nucleotide binding protein subunit 1 mutation in two siblings with pseudohypoparathyroidism tipe Ia and mother with pseudopseudohypoparathyroidism.
Eur J Pediatr, 158 (1999), pp. 200-203
[17.]
V.R. Arruda, W.D. Belangero, M.C. Ozelo, G.B. Oliveira, R.G. Pagnano, J.B. Volpon.
Inherited risk factors for trombophilia among children with Legg-Calve Perthes disease.
J Pediatr Orthop, 19 (1999), pp. 84-87
[18.]
J.P. Livesey, S.M. Hay, M.J. Bell.
Perthes disease affecting three female first-degree relatives.
J Pediatr Orthop, 7 (1998), pp. 230-231
Copyright © 2001. Asociación Española de Pediatría
Download PDF
Idiomas
Anales de Pediatría (English Edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?